...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Clinical trials query results

I'm having a difficult time rounding up all of the Clinical trials involving ZEN-3694

Found these two, both conducted outside Canada:

https://clinicaltrials.gov/ct2/show/NCT02711956

https://clinicaltrials.gov/ct2/show/NCT03901469

Looking for :

Metastatic Castration-Resistant Prostate Cancer (“mCRPC”) in combination with androgen receptor inhibitor, XTANDI

and

Androgen receptor-independent mCRPC in combination with immune checkpoint inhibitor KEYTRUDA and XTANDI

And are there more? I hoped that MD&A would recap all ClinicalTrials.gov identifiers (NCT numbers). If so I was not able to find it.

 

Koo

Share
New Message
Please login to post a reply